Neuron News and Research

RSS

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

Neurodegenerative disorders called frontotemporal dementias (FTD) are the second-leading cause of early-onset dementia in persons under age 65 and can emerge sometimes as early as age 20.

21 Sep 2009

Researchers link plasticity related gene-1 to lipid phosphates

In mice that are missing a protein found only in the brain, neural signals "go crazy," leaving the animals with epileptic seizures from a young age, researchers have found. The report in the September 18th Cell, a Cell Press publication, details what it is that happens when the protein encoded by plasticity related gene-1 (PRG-1) gets lost, revealing an important fine-tuning mechanism for brain function.

18 Sep 2009

Molecular link between intelligence and curiosity discovered

Scientists from the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto have discovered a molecular link between intelligence and curiosity, which may lead to the development of drugs to improve learning.

17 Sep 2009

UJI's current research study on early detection of Alzheimer's Disease using fMRI

The Universitat Jaume I (UJI) of Castelló is working on the early detection of Alzheimer's Disease by using functional magnetic resonance imaging (fMRI) techniques. The study is being carried out within the framework of a national project called MIND, which approaches Alzheimer's disease from a multidisciplinary perspective and involves twelve biomedicine companies and the corresponding public research organisations associated with them.

16 Sep 2009

Study describes neuron's two-layer integration model

A new Northwestern University study provides evidence that supports the "two-layer integration model," one of several competing models attempting to explain how neurons integrate synaptic inputs. The findings are published in the journal Neuron.

15 Sep 2009

WillWalk to raise funds for human stem cell trials for people with SCI

WillWalk, an Austin based non-profit organization has committed itself to be at the forefront of ending Paralysis. WillWalk will raise $3 million to help fund the first non-controversial human stem cell trials for people with Spinal Cord Injury (SCI).

14 Sep 2009

TrKA and CCM2 combination results in pediatric tumour regression

Why are some pediatric cancers able to spontaneously regress? Prof. Michael Fainzilber and his team of the Weizmann Institute's Biological Chemistry Department seem to have unexpectedly found part of the answer. Further research towards a better understanding of the mechanism of action might hopefully lead, in the future, to the development of drugs that will be able to induce regression of certain tumors.

10 Sep 2009

Capsule launches new Enterprise Medical Device Connectivity Solution

Capsule (www.capsuletech.com), the leading provider of medical device connectivity, today announces the release of their new Enterprise Medical Device Connectivity Solution enabled by the Capsule Neuron™.

10 Sep 2009

Merck's GARDASIL receives approval from FDA Advisory Committee

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.

10 Sep 2009

Researchers study the brain activity using magnetic resonance imaging

A woman looks familiar, but you can't remember her name or where you met her. New research by UC Irvine neuroscientists suggests the memory exists - you simply can't retrieve it.

10 Sep 2009

Capsule expands marketing program

After extensive planning, strategizing, and consulting, Capsule, the leading provider of medical device connectivity, has announced that they are expanding their marketing program to include social media. From Twitter, to Capsule's very own Facebook fan page, Capsule is ready to engage and gain new insights in order to better serve the clinical and HIT community.

8 Sep 2009

Researchers discover benefits of treating Alzheimer's disease with cancer drug

A drug now used to treat cancer may also be able to restore memory deficits in patients with Alzheimer's disease, according to a new study conducted by scientists at Columbia University Medical Center, which appeared in the September issue of the Journal of Alzheimer's Disease: Volume 18:1.

8 Sep 2009

Cancer drug could restore memory deficits in Alzheimer's patients

7 Sep 2009

Brain protein srGAP2 capable of forming filopodia

When the process goes awry, neurodevelopmental disorders such as mental retardation, dyslexia or autism may result. Researchers at the University of North Carolina at Chapel Hill School of Medicine have now discovered that establishing the neural wiring necessary to function normally depends on the ability of neurons to make finger-like projections of their membrane called filopodia.

5 Sep 2009

nSR100 protein plays a key role in neuron development

Researchers at the University of Toronto have identified a protein which plays a key role in the development of neurons, which could enhance our understanding of how the brain works, and how diseases such as Alzheimer's occur.

5 Sep 2009

Capsule parnters with Arcomed to provide connectivity between IV pumps and information systems

Arcomed AG, a global provider of IV pumps, and Capsule, the leading provider of medical device connectivity, today announced an agreement that promotes connectivity between Arcomed's IV pumps and hospital information systems using Capsule's leading vendor neutral connectivity solution.

4 Sep 2009

New study shows striking similarity in the evolution of cities and human brains

Cities are organized like brains, and the evolution of cities mirrors the evolution of human and animal brains, according to a new study by researchers at Rensselaer Polytechnic Institute.

3 Sep 2009

Capsule receives ISO-13485 certification for its data processing systems in the medical area

Capsule (www.capsuletech.com), the leading provider of medical device connectivity, announced today that it has received ISO-13485 certification for its headquarters in Paris, France and its US operation in Andover, MA.

2 Sep 2009

Office of Orphan Products Development of the FDA grants Orphan Drug Designation to Quinazoline495

Families of Spinal Muscular Atrophy (Libertyville, IL) announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted Orphan Drug Designation to Quinazoline495 for the treatment of Spinal Muscular Atrophy.

29 Aug 2009

Rutgers University Professor receives $3.5 million MERIT Award from NIH

Rutgers University Professor Dipak Sarkar has received a $3.5 million MERIT Award from the National Institutes of Health (NIH) to continue researching the damaging effects of alcohol on the nervous systems of the unborn.

27 Aug 2009